Abstract:Background Many preventive modalities have been advocated to reduce the incidence and severity of chemotherapy‐induced Oral Mucositis (OM). Photobiomodulation, also known as Low‐Level laser. Therapy, has shown promising results. This clinical trial was performed to evaluate the effectiveness of Photobiomodulation (PBM) for the prevention of chemotherapy‐induced oral mucositis (OM) in children with Acute Myeloid Leukemia (AML). Patients and methods A double‐blinded randomized clinical trial was performed, including forty‐two children diagnosed with Acute Myeloid Leukemia (AML) admitted to receiving chemotherapy (CT) at Children's Cancer Hospital 57357, Cairo, Egypt. Patients were randomly assigned to either the control or test group. Both groups followed the standard preventive protocol for oral mucositis. In the control group I sham therapy, while in the Laser group I had Photobiomodulation sessions for five consecutive days once a day performed by Diode laser (Sirrolaser Blue TM, USA) 660nm, 15watt, 10 s. Laser sessions began on day 1 of chemotherapy and were repeated on days 2,3, 4, and 5. The response to both groups was evaluated according to the development of oral mucositis; graded using the classification criteria of the World Health Organization (WHO) and the National Cancer Institute scale (NCI – Common Terminology Criteria for Adverse Events, version 4.0). Incidence of oral mucositis was evaluated from baseline to 5, 12, 19, and 30 days after treatment. Results A clinical significant difference between the laser and control group was observed. The laser group showed a higher prevalence of no oral mucositis with decreased incidence of OM, while on day 12, the control group showed a higher prevalence of grades I and II (P‐value <0.001, effect size = 0.796). However, the laser group showed higher prevalence of mucosa free of OM; on day 19, the control group showed higher rates of grades II and III, (P‐value <0.001, effect size = 0.670). while on day 30 there was higher rates of grades I and II (P‐value <0.001, effect size = 0.576) with higher rates of healthy oral mucosa in the laser group. Conclusion Photobiomodulation effectively reduces the incidence and severity of chemotherapy‐induced oral mucositis in pediatric patients diagnosed with AML.

Oral Mucositis In The Treatment Of Larynx Cancer In Patients Submitted To Prophylactic Photobiodulation.

The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma

Photobiomodulation Therapy In The Control Of Radio-Induced Oral Mucositis: Observational Retrospective Case-Control Study.

Might photobiomodulation therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma

Photobiomodulation for the prevention and treatment of oral mucositis in patients submitted to hematopoietic stem cell transplantation: health quality evaluation

Photobiomodulation As Therapy For Hyposalivation And Xerostomia In Patients Undergoing Radiotherapy: A Narrative Review.

Patient ́S Perception And Acceptance Of Intraoral And Extraoral Photobiomodulation For Prevention Of Oral Mucositis.

Effectiveness Of Photbiomodulation Therapy For Oral Mucositis Secondary To Antineoplasic Therapy: An Overview.

Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study

Underexplored Areas of Photobiomodulation in Oral Oncology: An Expert Analysis

Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial

Chemotherapy-induced oral mucositis: effect of LED and laser phototherapy treatment protocols

A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol

Photobiomodulation Therapy in the Prevention of Chemotherapy Induced Oral Mucositis in Children with Acute Myeloid Leukemia: A Randomized, Double‐blind, Clinical trial

Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation: randomised trial protocol

Evaluation Of The Oral Mucositis Grade In Oncopediatric Patients Undergoing Chemotherapy.

Evaluation of the Effect of Photobiomodulation on Radiation-Induced Xerostomia in Head and Neck Cancer Patients: A Randomized Clinical Trial

Interventions for preventing oral mucositis in people receiving cancer treatment: photobiomodulation

Photobiomodulation therapy on chemo- and radiotherapy induced oral conditions: an umbrella review

Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study

Radiotherapy-Induced Dysgeusia In Oral And Oropharyngeal Cancer Patients Undergoing Different Treatment Modalities.